Search NLS News

Mendus has received Fast Track Designation for its lead program, vididencel, for the treatment of Acute Myeloid Leukemia (AML) in complete remission with residual disease. “As part of the preparations for continued clinical development of vididencel in AML, we continue to strengthen the program in all product-relevant aspects, including on the regulatory front,” says Jeroen […]

This issue includes an exclusive profile interview with Jonina Gudmundsdottir, the CEO of the Icelandic CDMO Coripharma, and a special report on leadership, including advice from leadership expert Pär Skoglund Finquist and Sarah Lidé, the founder of VILDA, a Swedish network for female CEOs in the life science industry. Our hot topics in this issue are […]

Beactica Therapeutics has selected BEA-17 as a preclinical candidate for its LSD1 programme, aimed at finding new therapies for aggressive brain tumors and other life-threatening cancers. “We are thrilled to announce the selection of BEA-17 as a preclinical candidate. Reaching this remarkable milestone is a major achievement, as the vast majority of programmes fail before […]

The former state epidemiologist has been awarded the prestigious BiotechBuilders Award 2023, for his contribution during the pandemic. The following justification was: “This year’s winner of the BiotechBuilders Award goes to a person who started his life in Uppsala, trained as a doctor in Lund, completed his specialist training in Linköping and finally did his […]

Scandinavian CRO (SCRO) is a full-service contract research organization that helps industry and academia develop medicines and medical devices that improve patient health. For over 15 years, Founder & CEO Ulrika Hammarström has focused on building a sustainable company with a strong company culture and value-based leadership. As a two-time winner of the Gasell from […]

Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including Brazil in the exclusive collaboration and distribution agreement for Devyser’s post-transplant portfolio of NGS products. In addition to North America and Europe, Thermo Fisher will now exclusively market and sell Devyser’s transplantation products under combined brands also in Brazil. “We are very […]

Senzime has announces an initial order from a California-based hospital system. The order consists of 110 TetraGraph monitors as well as consumables and is the result of a comprehensive clinical and competitive product evaluation. “This is another fantastic milestone for Senzime and our largest US order to date from one of the greatest hospital systems […]

New figures from SCB (Statistics Sweden) show that pharmaceuticals are becoming an increasingly important export product as the positive trend continues and exports continue to grow in 2023. According to SCB, Sweden’s GDP decreased by 0.8 percent during the second quarter, with reduced goods exports the main explanation for the decline. The pharmaceutical industry, on […]

Genmab and Seagen have announced that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who received TIVDAK, compared with chemotherapy alone, met its primary endpoint of overall survival (OS). An Independent Data Monitoring Committee determined that OS crossed the pre-specified efficacy […]

Dynamic Code has acquired the bankrupt FindOut Diagnostic, a medical technology company that develops and manufactures self-tests. The company launched self-tests for CRP (rapid lowering) and HbA1c (long-term blood sugar) at the beginning of the year. The company’s products are well in line with Dynamic Code’s strategy to expand the product portfolio, the company states. […]